Minafin
FranceWho owns Minafin?
Minafin is a French Pharma company, currently owned by Quilvest Capital Partners since 2025 and 3 other investors. It changed hands in 2021, when Andera Partners sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Siparex, Motion Equity Partners, IRD Invest and Quilvest Capital Partners since 2017.
- ·Average hold across 2 realized cycles: 5 years.
- ·6 distinct PE sponsors across ownership cycles.
Ownership history
6 ownership periods · co-invest detected
Cathay Capital sold MINAFIN to Edmond de Rothschild Investment Partners and Siparex in 2017 after 6 years.
Andera Partners sold Minafin to Credit Mutuel Equity and Quilvest Capital Partners in 2021 after 4 years.
More from QCP Buyout Fund III
Other portfolio companies in the same fund.
US
More PE-backed in Industrials
Comparable industrials deals from other GPs.
UK
Germany
FinlandQuestions
Who owns Minafin?
Minafin is currently owned by Quilvest Capital Partners, IRD Invest and 2 others, through QCP Buyout Fund III, since 2025.
When did Quilvest Capital Partners and 3 others acquire Minafin?
Quilvest Capital Partners and 3 others acquired Minafin in 2025.
Who did Minafin sell to?
Andera Partners sold Minafin to Credit Mutuel Equity and Quilvest Capital Partners in 2021 (Secondary). Cathay Capital sold Minafin to Edmond de Rothschild Investment Partners and Siparex in 2017 (Secondary).
Who has owned Minafin over time?
Minafin has been through 6 private-equity ownership periods: Cathay Capital · via Cathay Capital Small Cap II · 2011–2017 · sold to Edmond de Rothschild Investment Partners and Siparex · (Secondary); Andera Partners · via Winch Capital 3 · 2017–2021 · sold to Credit Mutuel Equity and Quilvest Capital Partners · (Secondary); Siparex · via Siparex ETI 5 · since 2017; Motion Equity Partners · via Motion IV · since 2021; IRD Invest · via Nord Création · since 2024; Quilvest Capital Partners · via QCP Buyout Fund III · 2025–2021.